TP53 and non-small cell lung carcinoma: Aberrant JNK activation has been reported frequently in NSCLC [26,57], and a number of studies support the hypothesis that JNK has a favorable role in enhancing the growth of NSCLC as it promotes neoplastic transformation via negatively regulating p53 through c-Jun [58].